4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-19-044336
CIK 0001607678other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:59 PM ET
Size
5.4 KB
Accession
0001209191-19-044336
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-07-31+7,500→ 7,500 totalExercise: $7.69From: 2020-07-31Exp: 2029-07-31→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]1/3 of the shares subject to the option will vest on each anniversary of the grant date.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:59 PM ET
- Size
- 5.4 KB